Hawes E, Boortz K, Oeser J, ORourke M, OBrien R
J Mol Endocrinol. 2023; 71(4).
PMID: 37855366
PMC: 10616506.
DOI: 10.1530/JME-23-0070.
Wang H, Sang J, Ji Z, Yu Y, Wang S, Zhu Y
Molecules. 2023; 28(13).
PMID: 37446556
PMC: 10343216.
DOI: 10.3390/molecules28134894.
Mallipeddi P, Zhang Y, Li H, Markowitz S, Posner B
Molecules. 2021; 26(19).
PMID: 34641449
PMC: 8512612.
DOI: 10.3390/molecules26195903.
Labine M, DePledge L, Feirer N, Greenwich J, Fuqua C, Allen K
J Bacteriol. 2020; .
PMID: 32482721
PMC: 8404713.
DOI: 10.1128/JB.00098-20.
Stolterfoht H, Steinkellner G, Schwendenwein D, Pavkov-Keller T, Gruber K, Winkler M
Front Microbiol. 2018; 9:250.
PMID: 29515539
PMC: 5826065.
DOI: 10.3389/fmicb.2018.00250.
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.
Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S
Proc Natl Acad Sci U S A. 2017; 114(52):E11248-E11256.
PMID: 29229831
PMC: 5748222.
DOI: 10.1073/pnas.1716621115.
Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
Boyden L, Vincent N, Zhou J, Hu R, Craiglow B, Bayliss S
Am J Hum Genet. 2017; 100(6):978-984.
PMID: 28575652
PMC: 5473720.
DOI: 10.1016/j.ajhg.2017.05.003.
Chemistry of the retinoid (visual) cycle.
Kiser P, Golczak M, Palczewski K
Chem Rev. 2013; 114(1):194-232.
PMID: 23905688
PMC: 3858459.
DOI: 10.1021/cr400107q.
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.
Chapman K, Holmes M, Seckl J
Physiol Rev. 2013; 93(3):1139-206.
PMID: 23899562
PMC: 3962546.
DOI: 10.1152/physrev.00020.2012.
Mouse 11β-hydroxysteroid dehydrogenase type 2 for human application: homology modeling, structural analysis and ligand-receptor interaction.
Yamaguchi H, Akitaya T, Kidachi Y, Kamiie K, Noshita T, Umetsu H
Cancer Inform. 2011; 10:287-95.
PMID: 22174566
PMC: 3236009.
DOI: 10.4137/CIN.S8725.
Molecular docking and structural analysis of cofactor-protein interaction between NAD⁺ and 11β-hydroxysteroid dehydrogenase type 2.
Yamaguchi H, Akitaya T, Yu T, Kidachi Y, Kamiie K, Noshita T
J Mol Model. 2011; 18(3):1037-48.
PMID: 21667072
DOI: 10.1007/s00894-011-1140-2.
Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.
Lawson A, Walker E, Lavery G, Bujalska I, Hughes B, Arlt W
Proc Natl Acad Sci U S A. 2011; 108(10):4111-6.
PMID: 21325058
PMC: 3054023.
DOI: 10.1073/pnas.1014934108.
In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence.
Manning J, Bailey M, Soares D, Dunbar D, Mullins J
Physiol Genomics. 2010; 42(3):319-30.
PMID: 20571110
PMC: 2929884.
DOI: 10.1152/physiolgenomics.00053.2010.
Cryogenic and laser photoexcitation studies identify multiple roles for active site residues in the light-driven enzyme protochlorophyllide oxidoreductase.
Menon B, Waltho J, Scrutton N, Heyes D
J Biol Chem. 2009; 284(27):18160-6.
PMID: 19439417
PMC: 2709359.
DOI: 10.1074/jbc.M109.020719.
Characterization of key residues and membrane association domains in retinol dehydrogenase 10.
Takahashi Y, Moiseyev G, Farjo K, Ma J
Biochem J. 2008; 419(1):113-22, 1 p following 122.
PMID: 19102727
PMC: 2728083.
DOI: 10.1042/BJ20080812.
Aldo-keto reductases in which the conserved catalytic histidine is substituted.
Di Costanzo L, Penning T, Christianson D
Chem Biol Interact. 2008; 178(1-3):127-33.
PMID: 19028475
PMC: 2761211.
DOI: 10.1016/j.cbi.2008.10.046.
Molecular modeling and site-directed mutagenesis reveal the benzylisoquinoline binding site of the short-chain dehydrogenase/reductase salutaridine reductase.
Geissler R, Brandt W, Ziegler J
Plant Physiol. 2007; 143(4):1493-503.
PMID: 17337529
PMC: 1851842.
DOI: 10.1104/pp.106.095166.
Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors.
Miguet L, Zhang Z, Barbier M, Grigorov M
J Comput Aided Mol Des. 2006; 20(2):67-81.
PMID: 16783599
DOI: 10.1007/s10822-006-9037-3.
Directed evolution approach to a structural genomics project: Rv2002 from Mycobacterium tuberculosis.
Yang J, Park M, Waldo G, Suh S
Proc Natl Acad Sci U S A. 2003; 100(2):455-60.
PMID: 12524453
PMC: 141016.
DOI: 10.1073/pnas.0137017100.
Mutation of tyrosine-194 and lysine-198 in the catalytic site of pig 3alpha/beta,20beta-hydroxysteroid dehydrogenase.
Nakajin S, Takase N, Ohno S, Toyoshima S, Baker M
Biochem J. 1998; 334 ( Pt 3):553-7.
PMID: 9729461
PMC: 1219722.
DOI: 10.1042/bj3340553.